This site is intended for health professionals only

Published on 1 November 2007

Share this story:
Twitter
LinkedIn

The role of docetaxel (Taxotere) in head and neck squamous cell carcinoma (HNSCC) management

teaser

In the past 20 years concurrent chemoradiotherapy has gained popularity over induction chemotherapy (ICT). Positive trial results with docetaxel prompt the conclusion that ICT must be revisited.



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn